Abstract: A load-monitoring system includes a vehicle processor and a camera mounted in a trailer. The vehicle, via the processor, displays a first image of a trailer load, received from a trailer-mounted camera and receives selection of a monitoring point on the image, via a touch-sensitive user interface displaying the image or other selection mechanism. The vehicle also receives selection of a fixed point on the image, via the user interface. If the monitoring point moves more than a threshold amount, relative to the fixed point, for example, in subsequent images captured by the camera, the vehicle alerts the driver.

Abstract: This invention provides compounds of formula I and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.

Abstract: This invention provides compounds of formula I and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.

Abstract: An air circulation system is provided that is fittable to a protective helmet. The system includes an external manifold, a removable intake duct, and a removable exhaust duct. The manifold is mountable to an external surface of a protective shell of a helmet and defines an exhaust passage external of the shell having at least one orifice communicable with an interior crown region of the shell and an intake passage communicable with a bottom region of the shell near a wearer's mouth and nose. The removable intake duct is connected to a remote positive pressure source at one end and connected to the external intake passage on the other end. The removable exhaust duct is connected to a remote source of negative pressure at one end and connected to the external exhaust passage of the external manifold on the other end.

Abstract: A computer system and method support foreign exchange (FX) forward trading for both order posting and execution. The system includes a central server for tracking currency trades; a plurality of trading workstations; and at least one remote server interfacing the trading workstations to the central server, with the at least one remote server mediating the currency trades between traders using the workstations by consulting pre-set trading configurations associated with each trader. Currency brokers and traders use the system through a plurality of data input and display screens to deal in currency forwards in an efficient manner. The system and method support both voice and electronic data to interface with existing trading systems such as voice-based networks, permitting order entry anywhere in the world. The system includes features such as the filtering of entities by specified criteria such as bad credit, bad geography, etc.

Abstract: An air circulation system is provided that is fittable to a protective helmet. The system includes an external manifold, a removable intake duct, and a removable exhaust duct. The manifold is mountable to an external surface of a protective shell of a helmet and defines an exhaust passage external of the shell having at least one orifice communicable with an interior crown region of the shell and an intake passage communicable with a bottom region of the shell near a wearer's mouth and nose. The removable intake duct is connected to a remote positive pressure source at one end and connected to the external intake passage on the other end. The removable exhaust duct is connected to a remote source of negative pressure at one end and connected to the external exhaust passage of the external manifold on the other end.

Abstract: This invention provides compounds of formula I and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.

Abstract: This invention provides compounds of formula I and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.

Abstract: This invention provides compounds of formula I 1

Abstract: This invention provides compounds of formula I 1

Abstract: A method is described for forming a crystalline Echinocandin nucleus salt from its mixed broth and/or partially purified process streams by the steps of nanofiltration to form a concentrate, addition of an aldehyde derivatizing agent which interacts with an aldehyde impurity, addition of an acid/metal salt to form a solubilized echinocandin nucleus salt having the desired anion, and subsequent cooling of the mixture to crystallize the salt.

Abstract: A method is described for forming a crystalline Echinocandin nucleus salt from its mixed broth and/or partially purified process streams by the steps of nano-filtration to form a concentrate, addition of an aldehyde derivatizing agent which interacts with an aldehyde impurity, addition of an acid/metal salt to form a solubilized echinocandin nucleus salt having the desired anion, and subsequent cooling of the mixture to crystallize the salt.

Abstract: This invention provides compounds of formula I and pharmaceutically acceptable salts and solvates thereof, characterized that the compound is in particulate form and having a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula I, and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.